Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125409982 | 12540998 | 2 | F | 20160809 | 20160708 | 20160819 | EXP | RU-BAYER-2016-129866 | BAYER | CHERNOBROVKINA T.YA., YANKOVSKAYA YA.D., LITVINIVA O.S., OGANESYAN A.P.. ACHIEVEMENTS IN DIAGNOSIS AND TREATMENT ?F HEPATOCELLULAR CARCINOMA: CASE REPORT AND REVIEW. EPIDEMIOLOGY AND LNFECTIOUS DISEASES. 2016;21(2) | 59.00 | YR | A | F | Y | 0.00000 | 20160819 | OT | RU | RU |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125409982 | 12540998 | 1 | PS | NEXAVAR | SORAFENIB | 1 | 400 MG, BID | 21923 | 400 | MG | FILM-COATED TABLET | BID | |||||||
| 125409982 | 12540998 | 2 | C | SIOFOR | METFORMIN HYDROCHLORIDE | 1 | 500 MG | 0 | |||||||||||
| 125409982 | 12540998 | 3 | C | DIABETON [GLICLAZIDE] | 2 | 60 MG | 0 | ||||||||||||
| 125409982 | 12540998 | 4 | C | INDAPAMIDE W/PERINDOPRIL | INDAPAMIDEPERINDOPRIL | 1 | 0 | ||||||||||||
| 125409982 | 12540998 | 5 | C | DUPHALAC | LACTULOSE | 1 | 0 | ||||||||||||
| 125409982 | 12540998 | 6 | C | VIKASOL | 2 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125409982 | 12540998 | 1 | Hepatocellular carcinoma |
| 125409982 | 12540998 | 2 | Type 2 diabetes mellitus |
| 125409982 | 12540998 | 3 | Type 2 diabetes mellitus |
| 125409982 | 12540998 | 4 | Hypertension |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125409982 | 12540998 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125409982 | 12540998 | Alpha 1 foetoprotein increased | |
| 125409982 | 12540998 | Hepatocellular carcinoma |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |